Source: Annual Congress 2012 - Exercise testing in pulmonary arterial hypertension patients
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Garcia (Le Kremlin-Bicêtre, France). The clinical and prognostic evaluation of patients with PAH. Annual Congress 2012 - Exercise testing in pulmonary arterial hypertension patients

Member's Comments

No comment yet.

Related content which might interest you: The prognostic value of some clinical and laboratory parameters in sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 434s Year: 2002 The prognostic significance of different clinical, radiological and laboratory parameters in sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 46s Year: 2003 Clinical prognostic tools and their use in COPD. Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD Year: 2020 The clinical role of routine non-invasive parameters in the diagnostic work-up of patients with risk for pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012 Relevant prognostic predictors of sarcoidosis course Source: Eur Respir J 2001; 18: Suppl. 33, 345s Year: 2001 Pro-adrenomedullin as prognostic marker in patients with CAP Source: Annual Congress 2008 - Improved diagnosis and clinical decision-making by integrating information from new biomarkers Year: 2008 Determining the best diagnostic biomarker for sepsis and prognosis assessment Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 Clinical phenotyping of COPD patients: a simple tool with prognosis value Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Are biomarkers helpful in sepsis for risk assessment or clinical trials? Source: Annual Congress 2011 - Molecular biomarkers at the bedside of critically ill patients Year: 2011 Independent prognostic factors and prognostic classifications: how can we predict survival on the basis of clinical, pathological and routine biological factors? Source: Annual Congress 2011 - Prognostic and predictive factors in lung cancer Year: 2011 Immunological factors in NSCLC patients with possible predictive and prognostic value under PDL-1 treatment-a pilot study Source: International Congress 2019 – Treatment of lung cancer Year: 2019 Clinical evaluation and follow-up of patients with ILD Source: International Congress 2014 – MS01 Interdisciplinary diagnosis and evaluation of interstitial lung disease Year: 2014 Predictive value of clinical diagnosis in sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 345s Year: 2001 Exercise testing in the prognostic evaluation of patients with lung and heart diseases Source: Eur Respir Monogr 2018; 80: 222-234 Year: 2018 Importance of admission biomarkers in prognostication of  patients with SARS-Cov-2 Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure Year: 2021 Prognostic value of clinical exercise testing in adult patients with cystic fibrosis Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008 Comparison of prognostic significance of the quality of life questionnaires in patients with COPD combined with hypertension Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 Does sympathovagal imbalance predict clinical outcome in patients with PAH? Source: Annual Congress 2009 - Pulmonary arterial hypertension Year: 2009 Prognostic value of two clinical scores in patients with acute symptomatic pulmonary embolism Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011 Blood biomarkers predicting disease progression in patients with IPF: data from the INMARK trial Source: International Congress 2019 – The evolving field of idiopathic interstitial pneumonia Year: 2019